Quantcast

Subscribe

Vials of Adakveo, a new drug by Novartis, are lined up for distribution to help patients with sickle cell anemia.

Vials of Adakveo, a new drug by Novartis, are lined up for distribution to help patients with sickle cell anemia.

Stories this photo appears in:

Tease photo

New drug approved to manage sickle cell disease

U.S. regulators have approved a new medicine that can help reduce extremely painful sickle cell disease flare-ups.